Explore

Trendline Trendline
Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth

Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth

Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth
Trendline Trendline
Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting

Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting

Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting
Trendline Trendline
Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors to Enhance Financial Strategy

Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors to Enhance Financial Strategy

Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors to Enhance Financial Strategy
Trendline Trendline
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Enhance Innovation

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Enhance Innovation

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Enhance Innovation
Trendline Trendline
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Drive Innovation

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Drive Innovation

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Drive Innovation
Trendline Trendline
Fujifilm Unveils New Screening Platform for Cyclic Peptides Targeting Membrane Proteins

Fujifilm Unveils New Screening Platform for Cyclic Peptides Targeting Membrane Proteins

Fujifilm Unveils New Screening Platform for Cyclic Peptides Targeting Membrane Proteins
Trendline Trendline
VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy
Trendline Trendline
VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Gene Therapy Advances

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Gene Therapy Advances

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Gene Therapy Advances
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations
Trendline Trendline
4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA